BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 31560112)

  • 1. [Update on antithrombotic secondary prevention of ischemic stroke].
    Köhrmann M; Kleinschnitz C
    Nervenarzt; 2019 Oct; 90(10):995-1004. PubMed ID: 31560112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antithrombotic therapy in ischemic stroke and transient ischemic attack].
    Overgaard K; Poulsen TS; Husted SE
    Ugeskr Laeger; 2007 Oct; 169(40):3379-82. PubMed ID: 17953858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical practice. Secondary prevention after ischemic stroke or transient ischemic attack.
    Davis SM; Donnan GA
    N Engl J Med; 2012 May; 366(20):1914-22. PubMed ID: 22591297
    [No Abstract]   [Full Text] [Related]  

  • 4. Medical prevention of stroke and stroke recurrence in patients with TIA and minor stroke.
    Weber R; Weimar C; Diener HC
    Expert Opin Pharmacother; 2009 Aug; 10(12):1883-94. PubMed ID: 19558342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stroke subtypes and interventional studies for transient ischemic attack.
    Lavallée P; Amarenco P
    Front Neurol Neurosci; 2014; 33():135-46. PubMed ID: 24157562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antithrombotic and anticoagulation therapy after stroke and transient ischemic attacks].
    Weber R; Frank B; Diener HC
    Nervenarzt; 2010 Dec; 81(12):1509-17; quiz 1518-9. PubMed ID: 21181335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antithrombotic therapy in the secondary prevention of stroke].
    Mel'nikova EV; Kadinskaia MI; Gerasimenko DV; Shmonin AA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(12 Pt 2):23-7. PubMed ID: 21626814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antiplatelet treatment for secondary prevention of ischemic stroke or transient ischemic attack].
    Barinagarrementeria F; Arauz A; Ruiz-Sandoval JL; Cantú C; Leyva A; Murillo L; Villarreal J; Vargas RD; Alegría MA; Merino JG; Romano J;
    Rev Invest Clin; 2010; 62(2):135-40. PubMed ID: 20597393
    [No Abstract]   [Full Text] [Related]  

  • 9. Antithrombotic medication for stroke prevention.
    Weimar C; Weber R; Diener HC
    Expert Rev Cardiovasc Ther; 2009 Oct; 7(10):1245-54. PubMed ID: 19814667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk-benefit profile of long-term dual- versus single-antiplatelet therapy among patients with ischemic stroke: a systematic review and meta-analysis.
    Lee M; Saver JL; Hong KS; Rao NM; Wu YL; Ovbiagele B
    Ann Intern Med; 2013 Oct; 159(7):463-70. PubMed ID: 24081287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiplatelet, anticoagulant and fibrinolytic agents in acute ischaemic stroke and TIA.
    Sandercock P; Lindley R; Wardlaw J
    Br J Hosp Med; 1992 May 20-Jun 2; 47(10):731-7. PubMed ID: 1606457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral anticoagulants and non-cardioembolic stroke prevention.
    Schachter ME; Tran HA; Anand SS
    Vasc Med; 2008 Feb; 13(1):55-62. PubMed ID: 18372441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three-Case Report of Embolic Stroke of Undetermined Source.
    Li J; Yang XZ; Wang YP; Chen XL; Zhang X
    J Stroke Cerebrovasc Dis; 2017 Jul; 26(7):e133-e137. PubMed ID: 28476509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prescription of antithrombotic therapy in older patients hospitalized for transient ischemic attack and ischemic stroke: the GIFA study.
    Volpato S; Maraldi C; Blè A; Ranzini M; Rita Atti A; Dominguez LJ; Barbagallo M; Fellin R; Zuliani G;
    Stroke; 2004 Apr; 35(4):913-7. PubMed ID: 15001787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticoagulants versus antiplatelet therapy for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attack.
    Saxena R; Koudstaal P
    Cochrane Database Syst Rev; 2004 Oct; (4):CD000187. PubMed ID: 15494992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative efficacy and safety of multiple antiplatelet therapies for secondary prevention of ischemic stroke or transient ischemic attack: A network meta-analysis.
    Xiang RW; Han RB; Yang JY; Zhao MY; Zhao QC; Chen HS; Zhao FQ; Sun ZY; Zhao T; Song TY
    J Neurol Sci; 2019 Apr; 399():199-206. PubMed ID: 30849580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcomes using a platelet function-guided approach for secondary prevention in patients with ischemic stroke or transient ischemic attack.
    Depta JP; Fowler J; Novak E; Katzan I; Bakdash S; Kottke-Marchant K; Bhatt DL
    Stroke; 2012 Sep; 43(9):2376-81. PubMed ID: 22713488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary prevention by stroke subtype: a nationwide follow-up study in 46 108 patients after acute ischaemic stroke.
    Kim D; Lee SH; Joon Kim B; Jung KH; Yu KH; Lee BC; Roh JK;
    Eur Heart J; 2013 Sep; 34(35):2760-7. PubMed ID: 23729692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary prevention of ischaemic stroke and TIA.
    Diener HC
    Cardiovasc J Afr; 2008; 19(4):229. PubMed ID: 18776974
    [No Abstract]   [Full Text] [Related]  

  • 20. [Modern strategies for the management of patients who have suffered ischemic stroke or transient ischemic attack].
    Shirokov EA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(12. Vyp. 2):61-67. PubMed ID: 38148699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.